MedPath

Controls for Respiratory Diseases

Recruiting
Conditions
Bronchiectasis
Lung Cancer
Idiopathic Pulmonary Fibrosis
Chronic Obstructive Pulmonary Disease
Asthma
Nontuberculous Mycobacterium Infection
Registration Number
NCT03120481
Lead Sponsor
Seoul National University Hospital
Brief Summary

This is the registry of control participants for patients with various respiratory diseases. We screened healthy volunteers who visited Seoul National Hospital Healthcare System Gangnam Center for routine health check-up, and enrolled patients who agree to participate in the study. The participants undergo baseline questionnaires, provide blood specimen and information of the results of health check-up. We will include participants as controls if they have no significant respiratory symptom and no significant radiographic abnormality. The data from this registry will be compared with those from other registry of various respiratory diseases

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1572
Inclusion Criteria
  • 19-90 years old male and female
  • underwent health check-up including chest radiography
  • obtained informed consent
Exclusion Criteria
  • those who showed a significant abnormal finding of chest radiography
  • those who reported a significant respiratory symptoms

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality20 years

Death

Secondary Outcome Measures
NameTimeMethod
Hospitalization20 years

All cause hospitalization

Respiratory diseases diagnosis20 years

Respiratory diseases diagnosis

Respiratory hospitalization20 years

Hospitalization from respiratory causes

Trial Locations

Locations (1)

Seoul National University Healthcare System Gangnam Center

🇰🇷

Seoul, Korea, Republic of

Seoul National University Healthcare System Gangnam Center
🇰🇷Seoul, Korea, Republic of
Chang-Hoon Lee, M.D.
Contact
82-2-2072-4743
kauri670@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.